@article {Sullivan694, author = {Helen W. Sullivan and Amie C. O{\textquoteright}Donoghue and Kathryn J. Aikin}, title = {Primary Care Physicians{\textquoteright} Use of FDA-Approved Prescription Drug Labels}, volume = {27}, number = {5}, pages = {694--698}, year = {2014}, doi = {10.3122/jabfm.2014.05.140039}, publisher = {The Journal of the American Board of Family Medicine}, abstract = {Background: In 2006, the US Food and Drug Administration reorganized the approved label format and content for prescription drugs {\textemdash}also known as the prescribing information (PI). This research examines primary care physicians{\textquoteright} use of the new PI and how it may influence their perceptions about prescription drugs. Methods: A total of 500 physicians responded to an Internet survey that displayed an interactive PI for a fictitious combination pain relief/heart attack{\textendash}reducing drug. The physicians answered questions about perceived risk, perceived benefit, and intention to prescribe that focused on either the treatment indication or the prevention indication. Results: Physicians viewed PI sections in order, most often viewing sections relevant to safe use, such as Warnings and Precautions and Dosage and Administration. When asked to think about the drug{\textquoteright}s efficacy, many viewed the Clinical Studies section. Viewing certain PI sections was associated with greater perceived risk and lower perceived benefits and intention to prescribe. Conclusions: These results suggest that the information in the PI could affect physician decision making and do not support further reorganization of the PI.}, issn = {1557-2625}, URL = {https://www.jabfm.org/content/27/5/694}, eprint = {https://www.jabfm.org/content/27/5/694.full.pdf}, journal = {The Journal of the American Board of Family Medicine} }